HALOPERIDOL MEDICIANZ (Medsurge Pharma Pty Ltd)
Product name
HALOPERIDOL MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
haloperidol
Registration type
New generic medicine
Indication
Chronic Therapy
The management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, Gilles de la Tourette syndrome.
Short Term Therapy
The treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. In the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. Neuroleptanalgesia,/p>